R. Carter Pate, Director at BioScrip, Inc. (BIOS), bought 25,000 shares at $2.50 ($63K) on 2016-06-17, disclosed to the SEC on 2016-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OPCH | SELL | 2024-09-05 | $47K | — | Filing → |
| OPCH | BUY | 2023-08-21 | $101K | — | Filing → |
| PRPL | BUY | 2023-05-15 | $50K | — | Filing → |